Drug
pembrolizumab and berahyaluronidase alfa-pmph
Marketed as KEYTRUDA QLEX.
Generic name
pembrolizumab and berahyaluronidase alfa-pmph
Brand names
KEYTRUDA QLEX
First FDA approval
2025-09-19
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761467 | KEYTRUDA QLEX | 2025-09-19 | MERCK SHARP DOHME |
Manufacturers
MERCK SHARP DOHME
Frequently asked questions
When was pembrolizumab and berahyaluronidase alfa-pmph FDA approved?
Earliest FDA approval on record: 2025-09-19.
What brand names are sold as pembrolizumab and berahyaluronidase alfa-pmph?
KEYTRUDA QLEX.
Sources
Appeal a pembrolizumab and berahyaluronidase alfa-pmph denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com